EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The decay of HIV under anti-retroviral therapy is biphasic even in humanized mice with just T cells

Jasmine A F Kreig iD, Angela Wahl, Elisabete Fernandes, Jenna B Honeycutt iD, J Victor Garcia iD, Ruy M Ribeiro iD

Journal of Virology · 2026

DOI: 10.1128/jvi.01321-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Jasmine A F Kreig und 5 weiteren Autor:innen. Beteiligte Einrichtung: Theoretical Biology and Biophysics, Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, CD4-Positive T-Lymphocytes, Anti-HIV Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Fundacao para a Ciencia e Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV-1 plasma viral load decays in a biphasic manner during antiretroviral therapy (ART). It was hypothesized that this is due to infection of different cell types, namely CD4+ T cells and macrophages. We studied this possibility directly by modeling the decay of HIV-1 in humanized mice. We utilized previously published data from humanized T-cell only mice (TOM) and myeloid-only mice (MOM) infected with HIV-1 and treated with a potent ART regimen. Viral load decay dynamics were modeled using either a single or a biexponential decay fitted using nonlinear mixed effects techniques. Fits were compared using the corrected Bayesian information criterion (BICc). In TOM, the biphasic model was significantly better than a single-phase decay model (ΔBICc ≈ 16) despite additional parameters. In MOM, the biphasic decay was statistically better, but there was substantial uncertainty because the virus goes below detection very fast. The first-phase half-life was consistent between groups (1.2 days in MOM and 1.3 days in TOM) and similar to the half-life estimated in human infection. The second-phase decay in these mice was minimal likely due to low initial viral loads. Additional analyses with mice containing both CD4+ T cells and macrophages or X4-tropic virus-infected MOM mice confirmed the biphasic pattern, demonstrating the robustness of this result. The biphasic decline in HIV-1 occurs, even with only CD4+ T cells, refuting the hypothesis that distinct cell populations (CD4+ T cells and macrophages) drive each decay phase. These findings support an alternative model in which the observed dynamics arise from intrinsic properties of the viral infection lifecycle rather than from cellular compartmentalization. IMPORTANCE It is well known that when antiretroviral therapy is started in people infected with HIV, the decay of virus in the periphery is biphasic early on (followed by other slower phases). One possibility for this pattern of decay is infection of two different types of cells (suggested previously to be CD4+ T cells and macrophages), with different turnovers giving rise to the biphasic decline. We addressed this issue directly in a humanized mouse model of HIV, taking advantage of mice reconstituted with just T cells and treated with antiretroviral drugs. We found that the observed decay is biphasic, which eliminates the hypothesis that the biphasic decline is due to the co-existence of the two types of cells. It is possible that integration dynamics, as we previously proposed, are responsible for the observed biphasic decline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsCD4-Positive T-LymphocytesAnti-HIV AgentsAnti-Retroviral AgentsAnimalsMiceViral LoadHumansMacrophagesDisease Models, Animal

Stichwörter der Autor:innen

HIV-1 decaybiphasic declinecellular tropismhumanized mice

Substanzen

Anti-HIV AgentsAnti-Retroviral Agents

Autor:innen und Institutionen

  • Theoretical Biology and Biophysics, Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.
  • Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Faculdade de Medicina, Universidade de Lisboa, Lisbon, Lisbon, Portugal.
  • Division of Infectious Diseases, Center for AIDS Research, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

ORCID-Profile: Jasmine A F Kreig, Jenna B Honeycutt, J Victor Garcia, Ruy M Ribeiro

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Fundacao para a Ciencia e Tecnologia
  • Los Alamos National Laboratory

Zitieren

APA

Kreig, J. A. F., Wahl, A., Fernandes, E., Honeycutt, J. B., Garcia, J. V., & Ribeiro, R. M. (2026). The decay of HIV under anti-retroviral therapy is biphasic even in humanized mice with just T cells. Journal of Virology. https://doi.org/10.1128/jvi.01321-25

Vancouver

Kreig JAF, Wahl A, Fernandes E, Honeycutt JB, Garcia JV, Ribeiro RM. The decay of HIV under anti-retroviral therapy is biphasic even in humanized mice with just T cells. Journal of Virology. 2026. doi:10.1128/jvi.01321-25

BibTeX
@article{Kreig2026,
  author = {Kreig, Jasmine A F and Wahl, Angela and Fernandes, Elisabete and Honeycutt, Jenna B and Garcia, J Victor and Ribeiro, Ruy M},
  title = {The decay of HIV under anti-retroviral therapy is biphasic even in humanized mice with just T cells},
  journal = {Journal of Virology},
  year = {2026},
  doi = {10.1128/jvi.01321-25}
}
Kostenlos starten →